Novigenix raised €1.8M in a Grant round in Apr 2025. The company is based in Lausanne, Switzerland. Investors in the round: European Union (EU) research initiative. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €1.8M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
